U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:21:12 UTC 2021
Edited
by admin
on Sat Jun 26 18:21:12 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
M95KG522R0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OFATUMUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
HUMAX-CD20 2F2
Code English
HUMAX-CD20
Common Name English
OFATUMUMAB [USAN]
Common Name English
GSKI841157
Code English
HUMAX-CD20, 2F2
Code English
OFATUMUMAB [VANDF]
Common Name English
OFATUMUMAB [MART.]
Common Name English
GSK1841157
Code English
OFATUMUMAB [PURPLE BOOK, CDER]
Common Name English
OFATUMUMAB [JAN]
Common Name English
OFATUMUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
Common Name English
GSK-1841157
Code English
OFATUMUMAB [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
Common Name English
2F2
Common Name English
OFATUMUMAB [EMA EPAR]
Common Name English
ARZERRA
Brand Name English
OFATUMUMAB [INN]
Common Name English
HUMAX-CD20-2F2
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/08/581
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
EMA ASSESSMENT REPORTS ARZERRA (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
WHO-ATC L01XC10
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
NCI_THESAURUS C129822
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
LIVERTOX 703
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
WHO-VATC QL01XC10
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
NCI_THESAURUS C141215
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
FDA ORPHAN DRUG 275809
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
NDF-RT N0000175657
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
Code System Code Type Description
LACTMED
Ofatumumab
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
INN
8606
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
NCI_THESAURUS
C66952
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
DRUG BANK
DB06650
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
RXCUI
712566
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY RxNorm
MERCK INDEX
M8132
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY Merck Index
CAS
679818-59-8
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
EVMPD
SUB25221
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
WIKIPEDIA
Ofatumumab
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
MESH
C527517
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
DRUG CENTRAL
4951
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
ChEMBL
CHEMBL1201836
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
FDA UNII
M95KG522R0
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
HSDB
8170
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
PUBCHEM
6918251
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
IUPHAR
6778
Created by admin on Sat Jun 26 18:21:12 UTC 2021 , Edited by admin on Sat Jun 26 18:21:12 UTC 2021
PRIMARY
From To
1_22 1_96
1_149 1_205
1_225 3_214
1_231 2_231
1_234 2_234
1_266 1_326
1_372 1_430
2_22 2_96
2_149 2_205
2_225 4_214
2_266 2_326
2_372 2_430
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
TARGET->LIGAND
BINDING
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Vdss PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC Elimination
PHARMACOKINETIC